Form 4: Aspira Women's Health Director Exercises Restricted Stock Units
SEC Form 4 Filing
Director Ellen Beausang converted 1,615 restricted stock units into common stock of Aspira Women's Health Inc. on March 31, 2025.
Summary
- On March 31, 2025, Ellen Beausang, a director of Aspira Women's Health Inc., converted 1,615 restricted stock units (RSUs) into common stock.
- These RSUs were part of a grant of 6,458 RSUs awarded on March 11, 2025, with 1,615 vesting on March 31, 2025.
- Following the transaction, Ms. Beausang directly owns 1,615 shares of common stock and 4,843 RSUs.
Sentiment
Score: 5
Explanation: This is a neutral event; it's a standard transaction related to executive compensation.
Positives
- The director's conversion of RSUs into common stock could be interpreted as a sign of confidence in the company's future performance.
Industry Context
This is a routine disclosure related to insider transactions and is common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it represents a small portion of the company's outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Reporting person was granted 6,458 RSUs. |
| 03/31/2025 | 1,615 RSUs vested and were converted into common stock. |
| 04/01/2025 | Date of Form 4 filing. |
Keywords
Aspira Women's Health, Director, Ellen Beausang, Restricted Stock Units, RSUs, Common Stock, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.